From Yahoo Finance: 2025-04-15 12:22:00

Boston Scientific Corporation (BSX) is currently trading at $94.27 with a trailing P/E of 75.42 and a forward P/E of 33.11. The company is a leader in minimally invasive medical devices, focusing on innovation in areas such as cardiology, electrophysiology, and oncology. BSX has a market capitalization of $138.54B and a strong global footprint through acquisitions and operational efficiency. The company projects revenue growth between 12.5% and 14.5% for fiscal 2025, with a focus on emerging markets like China and Japan. Despite a premium valuation, BSX stands out in the MedTech space with its robust pipeline and long-term growth potential. Hedge funds remain invested in BSX, but some AI stocks may offer higher returns in a shorter timeframe.



Read more at Yahoo Finance: Boston Scientific Corporation (BSX): A Bull Case Theory